RELB and melanoma: Together, our findings suggest that melanoma cell adaptation to oncogenic MAPK pathway inhibition involves the interaction of tumor cells with the mesenchymal stroma enriched in fibrillar collagens, thereby promoting DDR‐dependent activation of the NF‐κB2/RelB pathway (Fig 9).